TABLE 1 Global Hereditary Angioedema Market By Drug Class, 2022-2032, USD (Million)
TABLE 2 Global Hereditary Angioedema Market By C1 Esterase Inhibitors, 2022-2032, USD (Million)
TABLE 3 Global Hereditary Angioedema Market By Kallikrien Inhibitor, 2022-2032, USD (Million)
TABLE 4 Global Hereditary Angioedema Market By Selective Bradykinin B2 Receptor Antagonist, 2022-2032, USD (Million)
TABLE 5 Global Hereditary Angioedema Market By Product Drugs, 2022-2032, USD (Million)
TABLE 6 Global Hereditary Angioedema Market By Phase III Drug, 2022-2032, USD (Million)
TABLE 7 Global Hereditary Angioedema Market By Phase II Drug (Qualitative Information), 2022-2032, USD (Million)
TABLE 8 North America Hereditary Angioedema Market By Drug Class, 2022-2032, USD (Million)
TABLE 9 North America Hereditary Angioedema Market By C1 Esterase Inhibitors, 2022-2032, USD (Million)
TABLE 10 North America Hereditary Angioedema Market By Kallikrien Inhibitor, 2022-2032, USD (Million)
TABLE 11 North America Hereditary Angioedema Market By Selective Bradykinin B2 Receptor Antagonist, 2022-2032, USD (Million)
TABLE 12 North America Hereditary Angioedema Market By Product Drugs, 2022-2032, USD (Million)
TABLE 13 North America Hereditary Angioedema Market By Phase III Drug, 2022-2032, USD (Million)
TABLE 14 North America Hereditary Angioedema Market By Phase II Drug (Qualitative Information), 2022-2032, USD (Million)
TABLE 15 U.S. Hereditary Angioedema Market By Drug Class, 2022-2032, USD (Million)
TABLE 16 U.S. Hereditary Angioedema Market By C1 Esterase Inhibitors, 2022-2032, USD (Million)
TABLE 17 U.S. Hereditary Angioedema Market By Kallikrien Inhibitor, 2022-2032, USD (Million)
TABLE 18 U.S. Hereditary Angioedema Market By Selective Bradykinin B2 Receptor Antagonist, 2022-2032, USD (Million)
TABLE 19 U.S. Hereditary Angioedema Market By Product Drugs, 2022-2032, USD (Million)
TABLE 20 U.S. Hereditary Angioedema Market By Phase III Drug, 2022-2032, USD (Million)
TABLE 21 U.S. Hereditary Angioedema Market By Phase II Drug (Qualitative Information), 2022-2032, USD (Million)
TABLE 22 Canada Hereditary Angioedema Market By Drug Class, 2022-2032, USD (Million)
TABLE 23 Canada Hereditary Angioedema Market By C1 Esterase Inhibitors, 2022-2032, USD (Million)
TABLE 24 Canada Hereditary Angioedema Market By Kallikrien Inhibitor, 2022-2032, USD (Million)
TABLE 25 Canada Hereditary Angioedema Market By Selective Bradykinin B2 Receptor Antagonist, 2022-2032, USD (Million)
TABLE 26 Canada Hereditary Angioedema Market By Product Drugs, 2022-2032, USD (Million)
TABLE 27 Canada Hereditary Angioedema Market By Phase III Drug, 2022-2032, USD (Million)
TABLE 28 Canada Hereditary Angioedema Market By Phase II Drug (Qualitative Information), 2022-2032, USD (Million)
TABLE 29 Rest of North America Hereditary Angioedema Market By Drug Class, 2022-2032, USD (Million)
TABLE 30 Rest of North America Hereditary Angioedema Market By C1 Esterase Inhibitors, 2022-2032, USD (Million)
TABLE 31 Rest of North America Hereditary Angioedema Market By Kallikrien Inhibitor, 2022-2032, USD (Million)
TABLE 32 Rest of North America Hereditary Angioedema Market By Selective Bradykinin B2 Receptor Antagonist, 2022-2032, USD (Million)
TABLE 33 Rest of North America Hereditary Angioedema Market By Product Drugs, 2022-2032, USD (Million)
TABLE 34 Rest of North America Hereditary Angioedema Market By Phase III Drug, 2022-2032, USD (Million)
TABLE 35 Rest of North America Hereditary Angioedema Market By Phase II Drug (Qualitative Information), 2022-2032, USD (Million)
TABLE 36 UK and European Union Hereditary Angioedema Market By Drug Class, 2022-2032, USD (Million)
TABLE 37 UK and European Union Hereditary Angioedema Market By C1 Esterase Inhibitors, 2022-2032, USD (Million)
TABLE 38 UK and European Union Hereditary Angioedema Market By Kallikrien Inhibitor, 2022-2032, USD (Million)
TABLE 39 UK and European Union Hereditary Angioedema Market By Selective Bradykinin B2 Receptor Antagonist, 2022-2032, USD (Million)
TABLE 40 UK and European Union Hereditary Angioedema Market By Product Drugs, 2022-2032, USD (Million)
TABLE 41 UK and European Union Hereditary Angioedema Market By Phase III Drug, 2022-2032, USD (Million)
TABLE 42 UK and European Union Hereditary Angioedema Market By Phase II Drug (Qualitative Information), 2022-2032, USD (Million)
TABLE 43 UK Hereditary Angioedema Market By Drug Class, 2022-2032, USD (Million)
TABLE 44 UK Hereditary Angioedema Market By C1 Esterase Inhibitors, 2022-2032, USD (Million)
TABLE 45 UK Hereditary Angioedema Market By Kallikrien Inhibitor, 2022-2032, USD (Million)
TABLE 46 UK Hereditary Angioedema Market By Selective Bradykinin B2 Receptor Antagonist, 2022-2032, USD (Million)
TABLE 47 UK Hereditary Angioedema Market By Product Drugs, 2022-2032, USD (Million)
TABLE 48 UK Hereditary Angioedema Market By Phase III Drug, 2022-2032, USD (Million)
TABLE 49 UK Hereditary Angioedema Market By Phase II Drug (Qualitative Information), 2022-2032, USD (Million)
TABLE 50 Germany Hereditary Angioedema Market By Drug Class, 2022-2032, USD (Million)
TABLE 51 Germany Hereditary Angioedema Market By C1 Esterase Inhibitors, 2022-2032, USD (Million)
TABLE 52 Germany Hereditary Angioedema Market By Kallikrien Inhibitor, 2022-2032, USD (Million)
TABLE 53 Germany Hereditary Angioedema Market By Selective Bradykinin B2 Receptor Antagonist, 2022-2032, USD (Million)
TABLE 54 Germany Hereditary Angioedema Market By Product Drugs, 2022-2032, USD (Million)
TABLE 55 Germany Hereditary Angioedema Market By Phase III Drug, 2022-2032, USD (Million)
TABLE 56 Germany Hereditary Angioedema Market By Phase II Drug (Qualitative Information), 2022-2032, USD (Million)
TABLE 57 Spain Hereditary Angioedema Market By Drug Class, 2022-2032, USD (Million)
TABLE 58 Spain Hereditary Angioedema Market By C1 Esterase Inhibitors, 2022-2032, USD (Million)
TABLE 59 Spain Hereditary Angioedema Market By Kallikrien Inhibitor, 2022-2032, USD (Million)
TABLE 60 Spain Hereditary Angioedema Market By Selective Bradykinin B2 Receptor Antagonist, 2022-2032, USD (Million)
TABLE 61 Spain Hereditary Angioedema Market By Product Drugs, 2022-2032, USD (Million)
TABLE 62 Spain Hereditary Angioedema Market By Phase III Drug, 2022-2032, USD (Million)
TABLE 63 Spain Hereditary Angioedema Market By Phase II Drug (Qualitative Information), 2022-2032, USD (Million)
TABLE 64 Italy Hereditary Angioedema Market By Drug Class, 2022-2032, USD (Million)
TABLE 65 Italy Hereditary Angioedema Market By C1 Esterase Inhibitors, 2022-2032, USD (Million)
TABLE 66 Italy Hereditary Angioedema Market By Kallikrien Inhibitor, 2022-2032, USD (Million)
TABLE 67 Italy Hereditary Angioedema Market By Selective Bradykinin B2 Receptor Antagonist, 2022-2032, USD (Million)
TABLE 68 Italy Hereditary Angioedema Market By Product Drugs, 2022-2032, USD (Million)
TABLE 69 Italy Hereditary Angioedema Market By Phase III Drug, 2022-2032, USD (Million)
TABLE 70 Italy Hereditary Angioedema Market By Phase II Drug (Qualitative Information), 2022-2032, USD (Million)
TABLE 71 France Hereditary Angioedema Market By Drug Class, 2022-2032, USD (Million)
TABLE 72 France Hereditary Angioedema Market By C1 Esterase Inhibitors, 2022-2032, USD (Million)
TABLE 73 France Hereditary Angioedema Market By Kallikrien Inhibitor, 2022-2032, USD (Million)
TABLE 74 France Hereditary Angioedema Market By Selective Bradykinin B2 Receptor Antagonist, 2022-2032, USD (Million)
TABLE 75 France Hereditary Angioedema Market By Product Drugs, 2022-2032, USD (Million)
TABLE 76 France Hereditary Angioedema Market By Phase III Drug, 2022-2032, USD (Million)
TABLE 77 France Hereditary Angioedema Market By Phase II Drug (Qualitative Information), 2022-2032, USD (Million)
TABLE 78 Rest of Europe Hereditary Angioedema Market By Drug Class, 2022-2032, USD (Million)
TABLE 79 Rest of Europe Hereditary Angioedema Market By C1 Esterase Inhibitors, 2022-2032, USD (Million)
TABLE 80 Rest of Europe Hereditary Angioedema Market By Kallikrien Inhibitor, 2022-2032, USD (Million)
TABLE 81 Rest of Europe Hereditary Angioedema Market By Selective Bradykinin B2 Receptor Antagonist, 2022-2032, USD (Million)
TABLE 82 Rest of Europe Hereditary Angioedema Market By Product Drugs, 2022-2032, USD (Million)
TABLE 83 Rest of Europe Hereditary Angioedema Market By Phase III Drug, 2022-2032, USD (Million)
TABLE 84 Rest of Europe Hereditary Angioedema Market By Phase II Drug (Qualitative Information), 2022-2032, USD (Million)
TABLE 85 Asia Hereditary Angioedema Market By Drug Class, 2022-2032, USD (Million)
TABLE 86 Asia Hereditary Angioedema Market By C1 Esterase Inhibitors, 2022-2032, USD (Million)
TABLE 87 Asia Hereditary Angioedema Market By Kallikrien Inhibitor, 2022-2032, USD (Million)
TABLE 88 Asia Hereditary Angioedema Market By Selective Bradykinin B2 Receptor Antagonist, 2022-2032, USD (Million)
TABLE 89 Asia Hereditary Angioedema Market By Product Drugs, 2022-2032, USD (Million)
TABLE 90 Asia Hereditary Angioedema Market By Phase III Drug, 2022-2032, USD (Million)
TABLE 91 Asia Hereditary Angioedema Market By Phase II Drug (Qualitative Information), 2022-2032, USD (Million)
TABLE 92 China Hereditary Angioedema Market By Drug Class, 2022-2032, USD (Million)
TABLE 93 China Hereditary Angioedema Market By C1 Esterase Inhibitors, 2022-2032, USD (Million)
TABLE 94 China Hereditary Angioedema Market By Kallikrien Inhibitor, 2022-2032, USD (Million)
TABLE 95 China Hereditary Angioedema Market By Selective Bradykinin B2 Receptor Antagonist, 2022-2032, USD (Million)
TABLE 96 China Hereditary Angioedema Market By Product Drugs, 2022-2032, USD (Million)
TABLE 97 China Hereditary Angioedema Market By Phase III Drug, 2022-2032, USD (Million)
TABLE 98 China Hereditary Angioedema Market By Phase II Drug (Qualitative Information), 2022-2032, USD (Million)
TABLE 99 Japan Hereditary Angioedema Market By Drug Class, 2022-2032, USD (Million)
TABLE 100 Japan Hereditary Angioedema Market By C1 Esterase Inhibitors, 2022-2032, USD (Million)
TABLE 101 Japan Hereditary Angioedema Market By Kallikrien Inhibitor, 2022-2032, USD (Million)
TABLE 102 Japan Hereditary Angioedema Market By Selective Bradykinin B2 Receptor Antagonist, 2022-2032, USD (Million)
TABLE 103 Japan Hereditary Angioedema Market By Product Drugs, 2022-2032, USD (Million)
TABLE 104 Japan Hereditary Angioedema Market By Phase III Drug, 2022-2032, USD (Million)
TABLE 105 Japan Hereditary Angioedema Market By Phase II Drug (Qualitative Information), 2022-2032, USD (Million)
TABLE 106 India Hereditary Angioedema Market By Drug Class, 2022-2032, USD (Million)
TABLE 107 India Hereditary Angioedema Market By C1 Esterase Inhibitors, 2022-2032, USD (Million)
TABLE 108 India Hereditary Angioedema Market By Kallikrien Inhibitor, 2022-2032, USD (Million)
TABLE 109 India Hereditary Angioedema Market By Selective Bradykinin B2 Receptor Antagonist, 2022-2032, USD (Million)
TABLE 110 India Hereditary Angioedema Market By Product Drugs, 2022-2032, USD (Million)
TABLE 111 India Hereditary Angioedema Market By Phase III Drug, 2022-2032, USD (Million)
TABLE 112 India Hereditary Angioedema Market By Phase II Drug (Qualitative Information), 2022-2032, USD (Million)
TABLE 113 Australia Hereditary Angioedema Market By Drug Class, 2022-2032, USD (Million)
TABLE 114 Australia Hereditary Angioedema Market By C1 Esterase Inhibitors, 2022-2032, USD (Million)
TABLE 115 Australia Hereditary Angioedema Market By Kallikrien Inhibitor, 2022-2032, USD (Million)
TABLE 116 Australia Hereditary Angioedema Market By Selective Bradykinin B2 Receptor Antagonist, 2022-2032, USD (Million)
TABLE 117 Australia Hereditary Angioedema Market By Product Drugs, 2022-2032, USD (Million)
TABLE 118 Australia Hereditary Angioedema Market By Phase III Drug, 2022-2032, USD (Million)
TABLE 119 Australia Hereditary Angioedema Market By Phase II Drug (Qualitative Information), 2022-2032, USD (Million)
TABLE 120 South Korea Hereditary Angioedema Market By Drug Class, 2022-2032, USD (Million)
TABLE 121 South Korea Hereditary Angioedema Market By C1 Esterase Inhibitors, 2022-2032, USD (Million)
TABLE 122 South Korea Hereditary Angioedema Market By Kallikrien Inhibitor, 2022-2032, USD (Million)
TABLE 123 South Korea Hereditary Angioedema Market By Selective Bradykinin B2 Receptor Antagonist, 2022-2032, USD (Million)
TABLE 124 South Korea Hereditary Angioedema Market By Product Drugs, 2022-2032, USD (Million)
TABLE 125 South Korea Hereditary Angioedema Market By Phase III Drug, 2022-2032, USD (Million)
TABLE 126 South Korea Hereditary Angioedema Market By Phase II Drug (Qualitative Information), 2022-2032, USD (Million)
TABLE 127 Latin America Hereditary Angioedema Market By Drug Class, 2022-2032, USD (Million)
TABLE 128 Latin America Hereditary Angioedema Market By C1 Esterase Inhibitors, 2022-2032, USD (Million)
TABLE 129 Latin America Hereditary Angioedema Market By Kallikrien Inhibitor, 2022-2032, USD (Million)
TABLE 130 Latin America Hereditary Angioedema Market By Selective Bradykinin B2 Receptor Antagonist, 2022-2032, USD (Million)
TABLE 131 Latin America Hereditary Angioedema Market By Product Drugs, 2022-2032, USD (Million)
TABLE 132 Latin America Hereditary Angioedema Market By Phase III Drug, 2022-2032, USD (Million)
TABLE 133 Latin America Hereditary Angioedema Market By Phase II Drug (Qualitative Information), 2022-2032, USD (Million)
TABLE 134 Brazil Hereditary Angioedema Market By Drug Class, 2022-2032, USD (Million)
TABLE 135 Brazil Hereditary Angioedema Market By C1 Esterase Inhibitors, 2022-2032, USD (Million)
TABLE 136 Brazil Hereditary Angioedema Market By Kallikrien Inhibitor, 2022-2032, USD (Million)
TABLE 137 Brazil Hereditary Angioedema Market By Selective Bradykinin B2 Receptor Antagonist, 2022-2032, USD (Million)
TABLE 138 Brazil Hereditary Angioedema Market By Product Drugs, 2022-2032, USD (Million)
TABLE 139 Brazil Hereditary Angioedema Market By Phase III Drug, 2022-2032, USD (Million)
TABLE 140 Brazil Hereditary Angioedema Market By Phase II Drug (Qualitative Information), 2022-2032, USD (Million)
TABLE 141 Mexico Hereditary Angioedema Market By Drug Class, 2022-2032, USD (Million)
TABLE 142 Mexico Hereditary Angioedema Market By C1 Esterase Inhibitors, 2022-2032, USD (Million)
TABLE 143 Mexico Hereditary Angioedema Market By Kallikrien Inhibitor, 2022-2032, USD (Million)
TABLE 144 Mexico Hereditary Angioedema Market By Selective Bradykinin B2 Receptor Antagonist, 2022-2032, USD (Million)
TABLE 145 Mexico Hereditary Angioedema Market By Product Drugs, 2022-2032, USD (Million)
TABLE 146 Mexico Hereditary Angioedema Market By Phase III Drug, 2022-2032, USD (Million)
TABLE 147 Mexico Hereditary Angioedema Market By Phase II Drug (Qualitative Information), 2022-2032, USD (Million)
TABLE 148 Rest of Latin America Hereditary Angioedema Market By Drug Class, 2022-2032, USD (Million)
TABLE 149 Rest of Latin America Hereditary Angioedema Market By C1 Esterase Inhibitors, 2022-2032, USD (Million)
TABLE 150 Rest of Latin America Hereditary Angioedema Market By Kallikrien Inhibitor, 2022-2032, USD (Million)
TABLE 151 Rest of Latin America Hereditary Angioedema Market By Selective Bradykinin B2 Receptor Antagonist, 2022-2032, USD (Million)
TABLE 152 Rest of Latin America Hereditary Angioedema Market By Product Drugs, 2022-2032, USD (Million)
TABLE 153 Rest of Latin America Hereditary Angioedema Market By Phase III Drug, 2022-2032, USD (Million)
TABLE 154 Rest of Latin America Hereditary Angioedema Market By Phase II Drug (Qualitative Information), 2022-2032, USD (Million)
TABLE 155 Middle East and Africa Hereditary Angioedema Market By Drug Class, 2022-2032, USD (Million)
TABLE 156 Middle East and Africa Hereditary Angioedema Market By C1 Esterase Inhibitors, 2022-2032, USD (Million)
TABLE 157 Middle East and Africa Hereditary Angioedema Market By Kallikrien Inhibitor, 2022-2032, USD (Million)
TABLE 158 Middle East and Africa Hereditary Angioedema Market By Selective Bradykinin B2 Receptor Antagonist, 2022-2032, USD (Million)
TABLE 159 Middle East and Africa Hereditary Angioedema Market By Product Drugs, 2022-2032, USD (Million)
TABLE 160 Middle East and Africa Hereditary Angioedema Market By Phase III Drug, 2022-2032, USD (Million)
TABLE 161 Middle East and Africa Hereditary Angioedema Market By Phase II Drug (Qualitative Information), 2022-2032, USD (Million)
TABLE 162 GCC Hereditary Angioedema Market By Drug Class, 2022-2032, USD (Million)
TABLE 163 GCC Hereditary Angioedema Market By C1 Esterase Inhibitors, 2022-2032, USD (Million)
TABLE 164 GCC Hereditary Angioedema Market By Kallikrien Inhibitor, 2022-2032, USD (Million)
TABLE 165 GCC Hereditary Angioedema Market By Selective Bradykinin B2 Receptor Antagonist, 2022-2032, USD (Million)
TABLE 166 GCC Hereditary Angioedema Market By Product Drugs, 2022-2032, USD (Million)
TABLE 167 GCC Hereditary Angioedema Market By Phase III Drug, 2022-2032, USD (Million)
TABLE 168 GCC Hereditary Angioedema Market By Phase II Drug (Qualitative Information), 2022-2032, USD (Million)
TABLE 169 Africa Hereditary Angioedema Market By Drug Class, 2022-2032, USD (Million)
TABLE 170 Africa Hereditary Angioedema Market By C1 Esterase Inhibitors, 2022-2032, USD (Million)
TABLE 171 Africa Hereditary Angioedema Market By Kallikrien Inhibitor, 2022-2032, USD (Million)
TABLE 172 Africa Hereditary Angioedema Market By Selective Bradykinin B2 Receptor Antagonist, 2022-2032, USD (Million)
TABLE 173 Africa Hereditary Angioedema Market By Product Drugs, 2022-2032, USD (Million)
TABLE 174 Africa Hereditary Angioedema Market By Phase III Drug, 2022-2032, USD (Million)
TABLE 175 Africa Hereditary Angioedema Market By Phase II Drug (Qualitative Information), 2022-2032, USD (Million)
TABLE 176 Rest of Middle East and Africa Hereditary Angioedema Market By Drug Class, 2022-2032, USD (Million)
TABLE 177 Rest of Middle East and Africa Hereditary Angioedema Market By C1 Esterase Inhibitors, 2022-2032, USD (Million)
TABLE 178 Rest of Middle East and Africa Hereditary Angioedema Market By Kallikrien Inhibitor, 2022-2032, USD (Million)
TABLE 179 Rest of Middle East and Africa Hereditary Angioedema Market By Selective Bradykinin B2 Receptor Antagonist, 2022-2032, USD (Million)
TABLE 180 Rest of Middle East and Africa Hereditary Angioedema Market By Product Drugs, 2022-2032, USD (Million)
TABLE 181 Rest of Middle East and Africa Hereditary Angioedema Market By Phase III Drug, 2022-2032, USD (Million)
TABLE 182 Rest of Middle East and Africa Hereditary Angioedema Market By Phase II Drug (Qualitative Information), 2022-2032, USD (Million)